Lisinopril Tablet
Product Images NDC 51655-399

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 51655-399). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (E299d477 A612 4af4 B6aa F5addc8a736d 01)

Chemical Structure (E299d477 A612 4af4 B6aa F5addc8a736d 01)
Chemical structure of Lisinopril dihydrate, showing its molecular arrangement including amine groups, carboxyl groups, and a phenyl group, consistent with the active ingredient Lisinopril.*
FDA Label Image

Label (51655 399 26 Rev B 02 22 Nhc)

Label (51655 399 26   Rev B 02 22 Nhc)
Label for Lisinopril Tablets USP 10 mg, containing 90 tablets. The label includes storage instructions to keep the product between 68°–77°F, protect from light, moisture, and freezing, and to store in the original container out of reach of children. It specifies the product is prescription only and is labeled by Northwind Health Company, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.